Struve Clayton A 4
4 · PRESSURE BIOSCIENCES INC · Filed Jan 2, 2013
Insider Transaction Report
Form 4
Struve Clayton A
10% Owner
Transactions
- Other
common stock
2012-12-28−1,000,000→ 228,600 total - Other
Series H Convertible Preferred
2012-12-28+10,000→ 10,000 total→ common stock (1,000,000 underlying)
Footnotes (5)
- [F1]Reporting Person has exchanged shares of common stock for Series H Convertible Preferred at a conversion ratio of one (1) preferred share to 100 common shares. Reporting Person has exchanged 1, 000,000 common shares for 10,000 Series H Convertible Preferred. This is a non-cash transaction. The Series H Convertible Preferred contains a limitation on conversion which prevents the Reporting Person from converting any Series H Convertible Preferred if, after giving effect to the conversion, the Reporting Person would beneficially own more than 4.99% of the outstanding shares of Common Stock. The Reporting Person may elect to increase this limitation to 9.99%, 14.99% or 19.99%, upon not less than 61 days prior written notice to the Company. The Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest in such securities.
- [F2]Reporting Person paid $0.8025 per share for common stock, since this is was a non-cash exchange of common stock for the Series H Convertible Preferred the reported price was the closing price of Company's common stock on the date of the exchange - $0.24. The Series H Convertible Preferred is convertible to common stock at a conversion price of $0.8025/share
- [F3]51,665 directly and 176,935 indirectly through css, llc
- [F4]Conversion ratio of one (1) series H preferred share to 100 common shares, based on conversion price at $0.8025/share.
- [F5]The Series H Convertible Preferred contain a limitation on conversion which prevents the Reporting Person from converting any Series H Convertible Preferred if, after giving effect to the conversion, the Reporting Person would beneficially own more than 4.99% of the outstanding shares of Common Stock. The Reporting Person may elect to increase this limitation to 9.99%, 14.99% or 19.99%, upon not less than 61 days prior written notice to the Company